Estrogen and progesterone measurement and its quality control in breast cancer: a reappraisal.
This article illustrates the two main methods for routine measurement of cytoplasmic estrogen receptor status in neoplastic biopsy. The first is the Dextran Coated Charcoal Technique (D.C.C. Assay) which is still the method of choice in the majority of clinical laboratories for its simplicity, reproducibility and low cost. The second is a more advanced technique based on the specific binding, enzymatically displayed, of commercially available antiestrogen monoclonal antibodies (Enzyme Immuno Assay - ABBOTT). The sui generis characteristics of endocrine sensitivity assessment on tumor tissues and the importance of decision-making connected with the assay justify rigorous quality assurance schemes. The quality control design proposed by the Italian Committee concerned the evaluation of several lyophilized preparations with scalar receptor content; this permits the identification through linear regression analysis of systematic and non-systematic errors. The Italian Committee has currently connected 50 labs from most regions of the country.
Piffanelli
A
A
Istituto di Radiologia, Università di Ferrara.
Giovannini
G
G
Pelizzola
D
D
De Bortoli
M
M
D000911:Antibodies, Monoclonal; D014408:Biomarkers, Tumor / Q000032:analysis*; D001943:Breast Neoplasms / Q000032:analysis*; D019411:Clinical Laboratory Techniques / Q000592:standards; D003600:Cytosol / Q000032:analysis; D005260:Female; D006801:Humans; D007124:Immunoenzyme Techniques; D011786:Quality Control; D011933:Reagent Kits, Diagnostic / Q000592:standards; D011960:Receptors, Estrogen / Q000032:analysis*; D011980:Receptors, Progesterone / Q000032:analysis*
D000911:Antibodies, Monoclonal; D014408:Biomarkers, Tumor; D011933:Reagent Kits, Diagnostic; D011960:Receptors, Estrogen; D011980:Receptors, Progesterone